Development and validation of tools for predicting the risk of death and ICU admission of non-HIV-infected patients with Pneumocystis jirovecii pneumonia

Development and validation of tools for predicting the risk of death and ICU admission of non-HIV-infected patients with Pneumocystis jirovecii pneumonia

IntroductionThe mortality rate of non-HIV-infected Pneumocystis jirovecii pneumonia (PCP) is high. This research aimed to develop and validate two clinical tools for predicting the risk of death and intensive care unit (ICU) admission in non-HIV-infected patients with PCP to reduce mortality.Methods...

Full description

Bibliographic Details
Main Authors: Fan Jin, Hao Liang, Wen-can Chen, Jing Xie, Huan-ling Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Public Health
Subjects:
Pneumocystis jirovecii pneumonia (PCP)
clinical tool
death risk
ICU admission
non-HIV
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.972311/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2022.972311/full

Similar Items